Mattern Wealth Management’s Comcast CMCSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,707
Closed -$1.55M 177
2024
Q1
$1.55M Sell
35,707
-635
-2% -$27.4K 0.38% 72
2023
Q4
$1.59M Buy
36,342
+2,872
+9% +$123K 0.41% 69
2023
Q3
$1.48M Buy
33,470
+1,637
+5% +$73.1K 0.44% 67
2023
Q2
$1.32M Buy
31,833
+2,301
+8% +$91.4K 0.39% 74
2023
Q1
$1.12M Sell
29,532
-2,320
-7% -$87.7K 0.37% 78
2022
Q4
$1.11M Sell
31,852
-170
-0.5% -$5.62K 0.45% 68
2022
Q3
$939K Sell
32,022
-121
-0.4% -$4.52K 0.38% 74
2022
Q2
$1.26M Buy
32,143
+14
+0% +$600 0.49% 59
2022
Q1
$1.5M Buy
32,129
+898
+3% +$43.3K 0.49% 61
2021
Q4
$1.57M Sell
31,231
-70
-0.2% -$3.65K 0.46% 55
2021
Q3
$1.75M Sell
31,301
-599
-2% -$34.9K 0.59% 45
2021
Q2
$1.84M Buy
31,900
+1,392
+5% +$77.8K 0.59% 45
2021
Q1
$1.65M Buy
30,508
+3,970
+15% +$210K 0.58% 46
2020
Q4
$1.39M Sell
26,538
-1,008
-4% -$48.3K 0.53% 55
2020
Q3
$1.27M Buy
27,546
+272
+1% +$11.8K 0.55% 57
2020
Q2
$1.06M Buy
27,274
+7,606
+39% +$290K 0.52% 60
2020
Q1
$676K Buy
+19,668
New +$830K 0.49% 66

Other funds holding CMCSA

Mattern Wealth Management's CMCSA Position: Q2 2024 in Review

Mattern Wealth Management sold out of Comcast (CMCSA) in Q2 2024, closing a stake of 35,707 shares — an estimated $1.55M sold.

Mattern Wealth Management first reported a position in CMCSA in Q1 2020 and held it in 17 quarters. The position peaked at $1.84M in Q2 2021. 2,341 funds tracked by Wall St. Rank hold CMCSA as of Q2 2024.

  • Mattern Wealth Management reported no remaining Comcast position as of Q2 2024 after selling out during the quarter.
  • Mattern Wealth Management sold 35,707 Comcast shares in Q2 2024, an estimated $1.55M.
  • Mattern Wealth Management first reported a position in Comcast in Q1 2020 and held it in 17 quarters.
  • Mattern Wealth Management's Comcast position peaked at $1.84M in Q2 2021.
  • 2,341 funds tracked by Wall St. Rank held Comcast as of Q2 2024.

Based on Mattern Wealth Management's 13F filing for Q2 2024, filed 17 Jul 2024.